Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by Snippy1on Nov 18, 2017 2:48am
222 Views
Post# 26988558

RE:acb-cmed-hip

RE:acb-cmed-hip
Dontbesogreedy wrote:
don't get me wrong I am not against ACB buying cmed...

but I think it should be done in a civilized way

ACB is REALLY worth about 2$ a share, the new cmed+hip is worth north of 30$....so sure give us 25 shares of ACB for 1 share of cmed and I'll consider your offer reasonable...maybe


you want US more than we want you

just saying

lol Canimed is dead in the water compared to the LPs that actually have tangible expansions that will generate huge revenues.  Canimed had first mover advantage and completely fumbled the opportunity into oblivion.  Truth be told they don't deserve a second chance for the massive opportunity that they completely wasted.  You should be thanking ACB for attempting to resuurect your decrepit skeleton of a LP marijuana company.

ps... we don't want you ACB


<< Previous
Bullboard Posts
Next >>